MGRO — MustGrow Biologics Balance Sheet
0.000.00%
Last trade - 00:00
- CA$37.57m
- CA$32.44m
- CA$4.71m
- 70
- 18
- 10
- 24
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 4.03 | 3.31 | 9.62 | 7.02 | 6.82 |
Net Total Receivables | 0.056 | 0.033 | 0.064 | 0.088 | 0.095 |
Prepaid Expenses | |||||
Total Current Assets | 4.09 | 3.37 | 9.7 | 7.13 | 6.94 |
Total Assets | 4.09 | 3.37 | 9.7 | 7.13 | 6.94 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.679 | 0.351 | 0.863 | 1.54 | 1.21 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.06 | 1.05 | 1.25 | 1.9 | 1.35 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 3.03 | 2.32 | 8.46 | 5.24 | 5.58 |
Total Liabilities & Shareholders' Equity | 4.09 | 3.37 | 9.7 | 7.13 | 6.94 |
Total Common Shares Outstanding |